Results 111 to 120 of about 55,033 (326)

On the efficient evaluation of the azimuthal Fourier components of the Green's function for Helmholtz's equation in cylindrical coordinates. [PDF]

J Comput Phys, 2022
Garritano J, Kluger Y, Rokhlin V, Serkh K.   +3 more
europepmc   +1 more source

Green's Function for Two-Dimensional Magnetohydrodynamic Waves. II [PDF]

, 1961
Harold Weitzner
openalex   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Reactivity of anatase (001) surface from first-principles many-body Green's function theory. [PDF]

RSC Adv, 2022
Jin F, Zhao Z.
europepmc   +1 more source

The Approximate Expression of Green's Function for the Calculation of Electronic Structure in Metals and Alloys [PDF]

, 1969
Junjiro Kanamori, Kiyoyuki Terakura, Kōsaku Yamada   +2 more
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Green's functions and Riemann's method [PDF]

, 1965
A. G. Mackie
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Equation-of-Motion Coupled-Cluster Cumulant Green's Function for Excited States and X-Ray Spectra. [PDF]

Front Chem, 2021
Vila FD, Kas JJ, Rehr JJ, Kowalski K, Peng B.   +4 more
europepmc   +1 more source

Perturbation Expansion for Real-Time Green's Functions [PDF]

, 1968
Richard A. Craig
openalex   +1 more source